SCHEMBL13368336

SCHEMBL13368336

O=CCc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.63
SLC2A1 P11166 5/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
GABRA2 P47869 1/20 0.57
GABRB2 P47870 1/20 0.57
KDM4E B2RXH2 1/20 0.56
HTT P42858 1/20 0.56
TSPO P30536 2/20 0.55
NR1I2 O75469 1/20 0.55
ABCB11 O95342 1/20 0.55
ALB P02768 1/20 0.55
ADORA3 P0DMS8 1/20 0.55
ADORA1 P30542 1/20 0.55
OPRM1 P35372 1/20 0.55
DRD3 P35462 1/20 0.55
OPRK1 P41145 1/20 0.55
PDE4D Q08499 1/20 0.55
KCNH2 Q12809 1/20 0.55
SIRT5 Q9NXA8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13368337 0.83 KDM4E (0.64) SLC2A1GABRB2KDM4EHTT
Hydrochloric Acid SCHEMBL1429987 0.81 ALDH1A1 (0.68) ALDH1A1SLC2A1MEN1KMT2AGABRA2
SCHEMBL1691241 0.81 ALDH1A1 (0.68) ALDH1A1SLC2A1MEN1KMT2AGABRA2
SCHEMBL2932378 0.80 GABRA1 (0.61) ALDH1A1SLC2A1GABRA2GABRB2KDM4E
SCHEMBL8150 0.79 GABRA2 (0.70) ALDH1A1SLC2A1MEN1KMT2AGABRA2
SCHEMBL7261 0.78 GABRA2 (0.68) ALDH1A1SLC2A1MEN1KMT2AGABRA2
SCHEMBL7655591 0.78 ALDH1A1 (0.52) ALDH1A1SLC2A1MEN1KMT2AGABRA2
SCHEMBL1431867 0.77 ALDH1A1 (0.63) ALDH1A1SLC2A1MEN1KMT2AGABRA2
SCHEMBL2195258 0.77 SLC2A1 (0.66) ALDH1A1SLC2A1MEN1KMT2AGABRA2
SCHEMBL7995 0.77 ALDH1A1 (0.63) ALDH1A1SLC2A1MEN1KMT2AGABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723324-B2 Imidazo[1,2-A]pyridine anxiolytics SEPRACOR, INC. (US) 2010-05-25 US disclosed
US-20080096867-A1 Imidazo[1,2-A] Pyridine Anxiolytics SEPRACOR INC. (US) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096867-A1 Imidazo[1,2-A] Pyridine Anxiolytics MTNR1B, ADORA2B, ADRA2B ALDH1A1 321/4885SLC2A1 4352/4885MEN1 3265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.